Armistice Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.57M	Sell	172,000 -28,000	-14%	-$419K	0.04%	120
2025 Q1	$3.23M	Hold	200,000	–	–	0.05%	128
2024 Q4	$4.66M	Buy	200,000 +64,000	+47%	+$1.49M	0.06%	120
2024 Q3	$4M	Hold	136,000	–	–	0.06%	128
2024 Q2	$3.2M	Buy	+136,000	New	+$3.2M	0.04%	129